These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2143593

  • 1. Vasomotor rhinitis and the systemic absorption of ipratropium bromide.
    Kaila T, Suonpää J, Grénman R, Iisalo E.
    Rhinology; 1990 Jun; 28(2):83-9. PubMed ID: 2143593
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide.
    Laurikainen E, Koulu M, Kaila T, Scheinin M, Isalo E.
    Rhinology; 1988 Jun; 26(2):133-8. PubMed ID: 2972054
    [Abstract] [Full Text] [Related]

  • 3. Intranasal ipratropium in the treatment of vasomotor rhinitis.
    Jokinen K, Sipilä P.
    Rhinology; 1983 Dec; 21(4):341-5. PubMed ID: 6229864
    [Abstract] [Full Text] [Related]

  • 4. The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study.
    Sjögren I, Jonsson L, Köling A, Jansson C, Osterman K, Håkansson B.
    Acta Otolaryngol; 1988 Dec; 106(5-6):453-9. PubMed ID: 2974675
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion.
    Ostberg B, Winther B, Borum P, Mygind N.
    Rhinology; 1997 Jun; 35(2):58-62. PubMed ID: 9299652
    [Abstract] [Full Text] [Related]

  • 9. The use of intranasal Atrovent in the treatment of vasomotor rhinitis.
    Hosen H.
    Ann Allergy; 1987 Nov; 59(5):384. PubMed ID: 2961291
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of oxitropium bromide and ipratropium bromide in asthma.
    Peel ET, Anderson G, Cheong B, Broderick N.
    Eur J Respir Dis; 1984 Feb; 65(2):106-8. PubMed ID: 6230249
    [Abstract] [Full Text] [Related]

  • 11. [Nasal hypersecretion treated with ipratropium].
    Borum P.
    Lakartidningen; 1980 May 21; 77(21):2038-9. PubMed ID: 6447235
    [No Abstract] [Full Text] [Related]

  • 12. Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients.
    Malmberg H, Grahne B, Holopainen E, Binder E.
    Clin Otolaryngol Allied Sci; 1983 Aug 21; 8(4):273-6. PubMed ID: 6228347
    [Abstract] [Full Text] [Related]

  • 13. Nasal disorders and anticholinergic therapy.
    Borum P.
    Postgrad Med J; 1987 Aug 21; 63 Suppl 1():61-8. PubMed ID: 2962076
    [Abstract] [Full Text] [Related]

  • 14. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.
    Georgitis JW, Banov C, Boggs PB, Dockhorn R, Grossman J, Tinkelman D, Roszko P, Wood C.
    Clin Exp Allergy; 1994 Nov 21; 24(11):1049-55. PubMed ID: 7874603
    [Abstract] [Full Text] [Related]

  • 15. Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea.
    Borum S, Becker B, Mygind N, Borum P.
    Rhinology; 1996 Dec 21; 34(4):198-200. PubMed ID: 9050095
    [Abstract] [Full Text] [Related]

  • 16. Intranasal ipratropium: literature abstracts and comments.
    Mygind N, Borum P.
    Rhinol Suppl; 1989 Dec 21; 9():37-44. PubMed ID: 2534054
    [Abstract] [Full Text] [Related]

  • 17. Product characteristics and pharmacokinetics of intranasal ipratropium bromide.
    Wood CC, Fireman P, Grossman J, Wecker M, MacGregor T.
    J Allergy Clin Immunol; 1995 May 21; 95(5 Pt 2):1111-6. PubMed ID: 7751527
    [Abstract] [Full Text] [Related]

  • 18. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia.
    Sapci T, Yazici S, Evcimik MF, Bozkurt Z, Karavus A, Ugurlu B, Ozkurt E.
    Rhinology; 2008 Mar 21; 46(1):45-51. PubMed ID: 18444492
    [Abstract] [Full Text] [Related]

  • 19. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology.
    Meltzer EO, Orgel HA, Bronsky EA, Findlay SR, Georgitis JW, Grossman J, Ratner P, Wood CC.
    J Allergy Clin Immunol; 1992 Aug 21; 90(2):242-9. PubMed ID: 1386857
    [Abstract] [Full Text] [Related]

  • 20. A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma.
    Salo D, Tuel M, Lavery RF, Reischel U, Lebowitz J, Moore T.
    J Emerg Med; 2006 Nov 21; 31(4):371-6. PubMed ID: 17046476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.